HIV/AIDS Clinical Trials in Houston

Showing 241-260 of 470 trials

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

NCT00100984

The main objective of this study is to compare the safety and efficacy of an enfuvirtide containing regimen to a nucleoside combination regimen. Resistance information will also be collected.

HIV Infection

Hoffmann-La Roche8 participantsStarted Jul 2004

Hobson City, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +17 more locations

COMPLETEDPhase 4< 1 mile

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

NCT00082394

The aim of this study was to assess whether TRIZIVIR, administered twice-daily was as safe, tolerable and efficacious as a combination of the drugs COMBIVIR administered twice-daily and atazanavir administered once daily. Over the course of 48 weeks, various parameters that measure safety, tolerability and efficacy of the investigational drugs were measured and compared.

Infection, Human Immunodeficiency Virus IHIV Infection

GlaxoSmithKlineStarted Apr 2004

Bakersfield, California, United States • Los Angeles, California, United States • Oakland, California, United States +42 more locations

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

HIV/AIDS Trials in Other Cities

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

PRO 140 for Human Immunodeficiency Virus Infection

Factors Affecting PrEP Adherence

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

GW873140 In Combination With Combivir In HIV Infected Subjects

Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

Engaging Care for HIV-infected Adolescent Females.

A Novel Method to Determine HIV Incidence Among Youth

Immunologic Memory (Supp. of ATN 024)

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Other Conditions in Houston